National Register of Oesophageal Atresia (REGATE)
Sponsor: University Hospital, Lille
Listed as NCT02883725, this observational or N/A phase trial focuses on Esophageal Atresia and remains ongoing. Sponsored by University Hospital, Lille, it has been updated 12 times since 2008, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Feb 2026 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2025 — Feb 2026 [monthly]
Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jun 2022 — Jul 2024 [monthly]
Recruiting
▶ Show 7 earlier versions
-
May 2021 — Jun 2022 [monthly]
Recruiting
-
Jan 2021 — May 2021 [monthly]
Recruiting
-
Sep 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2019 — Sep 2020 [monthly]
Recruiting
-
Jun 2018 — Jun 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jan 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Lille
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Amiens, France , Angers, France , Besançon, France , Bordeaux, France , Brest, France , Bron, France , Caen, France , Clermont-Ferrand, France , Colmar, France , Créteil, France and 24 more locations